A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

Angelina Jolie has shockingly faced a torrent of callous online abuse after boldly baring the scars from her double ...

Angelina Jolie has surprisingly faced a wave of online abuse. Her recent photoshoot for TIME France is now being viewed as an ...

The Phase 3 AMPLITUDE trial led by UCL found that adding the PARP inhibitor niraparib to standard hormone therapy may slow progression of hormone-sensitive prostate cancer in men with DNA repair gene ...

In this retrospective study, researchers aimed to characterize persistent toxicities experienced by patients with TNBC who were treated with pembrolizumab in the curative setting.

Actress Angelina Jolie shares her mastectomy scars 10 years on, spotlighting genetic risk, early detection, and the ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

Cedars Sinai gets 30M to establish a specialized BRCA cancer center focusing on research, diagnosis, and treatment in Los Angeles.

Angelina Jolie reveals why she chose a preventive double mastectomy to reduce her cancer risk Here’s a detailed look at her ...

The FDA converted the PARP inhibitor's 2020 accelerated approval to full approved based on results from the Phase III TRITON3 trial.

In a bold move, Hollywood icon Angelina Jolie publicly shared her choice to undergo a double mastectomy, a decision rooted in her personal battle. Thi ...